José Aguado to Immunoglobulins, Intravenous
This is a "connection" page, showing publications José Aguado has written about Immunoglobulins, Intravenous.
Connection Strength
0.402
-
Intravenous immunoglobulins for the treatment of the hyper-inflammatory response in COVID-19. Another failure of immunomodulatory therapy? Clin Microbiol Infect. 2021 10; 27(10):1386-1388.
Score: 0.379
-
Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient. Transpl Infect Dis. 2021 Apr; 23(2):e13501.
Score: 0.023